1
|
Tenesa A and Dunlop MG: New insights into
the aetiology of colorectal cancer from genome-wide association
studies. Nat Rev Genet. 10:353–358. 2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Gu S, Jin L, Zhang F, Sarnow P and Kay MA:
Biological basis for restriction of microRNA targets to the 3′
untranslated region in mammalian mRNAs. Nat Struct Mol Biol.
16:144–150. 2009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
5
|
Xi Y, Shalgi R, Fodstad O, Pilpel Y and Ju
J: Differentially regulated micro-RNAs and actively translated
messenger RNA transcripts by tumor suppressor p53 in colon cancer.
Clin Cancer Res. 12:2014–2024. 2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
O'Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005. View Article : Google Scholar : PubMed/NCBI
|
7
|
Woods K, Thomson JM and Hammond SM: Direct
regulation of an oncogenic micro-RNA cluster by E2F transcription
factors. J Biol Chem. 282:2130–2134. 2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe
SW, Hannon GJ and Hammond SM: A microRNA polycistron as a potential
human oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
9
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack
FJ: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
10
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
11
|
Roldo C, Missiaglia E, Hagan JP, Falconi
M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A and
Croce CM: MicroRNA expression abnormalities in pancreatic endocrine
and acinar tumors are associated with distinctive pathologic
features and clinical behavior. J Clin Oncol. 24:4677–4684. 2006.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Ventura A and Jacks T: MicroRNAs and
cancer: Short RNAs go a long way. Cell. 136:586–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et
al: MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Díaz R, Silva J, García JM, Lorenzo Y,
García V, Peña C, Rodríguez R, Muñoz C, García F, Bonilla F and
Domínguez G: Deregulated expression of miR-106a predicts survival
in human colon cancer patients. Genes Chromosomes Cancer.
47:794–802. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Link A, Balaguer F, Shen Y, Nagasaka T,
Lozano JJ, Boland CR and Goel A: Fecal MicroRNAs as novel
biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers
Prev. 19:1766–1774. 2010. View Article : Google Scholar : PubMed/NCBI
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Calin GA, Liu CG, Sevignani C, Ferracin M,
Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, et al:
MicroRNA profiling reveals distinct signatures in B cell chronic
lymphocytic leukemias. Proc Natl Acad Sci USA. 101:11755–11760.
2004. View Article : Google Scholar : PubMed/NCBI
|
18
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
19
|
Jovanovic M and Hengartner MO: miRNAs and
apoptosis: RNAs to die for. Oncogene. 25:6176–6187. 2006.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Kent OA and Mendell JT: A small piece in
the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
Oncogene. 25:6188–6196. 2006. View Article : Google Scholar : PubMed/NCBI
|
21
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Yang G, Zhang R, Chen X, Mu Y, Ai J, Shi
C, Liu Y, Shi C, Sun L, Rainov NG, et al: MiR-106a inhibits glioma
cell growth by targeting E2F1 independent of p53 status. J Mol Med
(Berl). 89:1037–1050. 2011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Kim K, Chadalapaka G, Lee SO, Yamada D,
Sastre-Garau X, Defossez PA, Park YY, Lee JS and Safe S:
Identification of oncogenic microRNA-17-92/ZBTB4/specificity
protein axis in breast cancer. Oncogene. 31:1034–1044. 2012.
View Article : Google Scholar : PubMed/NCBI
|